Previous 10 | Next 10 |
Cinedigm CIDM +31% on Q4 earnings.Huadi International (HUDI) +27%.Verb Technology (VERB) +20%.Datasea (DTSS) +21%.Alterity Therapeutics (ATHE) +17%.Arlo Technologies (ARLO) +13%.Navidea Biopharmaceuticals NAVB +13% surge on regulatory update for rheumatoid arthritis ...
Gainers: SGOCO Group (SGOC) +250%.Stamps.com STMP +64%.ToughBuilt Industries TBLT +48%.Carver Bancorp CARV +39%.Galectin Therapeutics GALT +33%.Tempest Therapeutics (TPST) +20%.Sequential Brands Group (SQBG) +19%.LMP Automotive LMPX +18%.Grupo Simec, S.A.B. de C.V. (S...
Gainers: Galectin Therapeutics GALT +40%, ReShape Lifesciences (RSLS) +21%, INmune Bio (INMB) +17%, ASLAN Pharmaceuticals (ASLN) +15%, 89bio (ETNB) +14%.Losers: Sigilon Therapeutics SGTX -30%, Aerpio Pharmaceuticals (ARPO) -14%, Alterity ...
Nova LifeStyle (NVFY) -27%.Aerpio Pharmaceuticals (ARPO) -9%.Xtant Medical (XTNT) -7%.LM Funding America (LMFA) -9%.Creatd (CRTD) -8%.United Time Technology (UTME) -8%.TESSCO Technologies (TESS) -8%.Blonder Tongue Laboratories (BDR) -7%.SGOCO Group (SGOC) -7%.Alterity Therapeutics (ATHE) -6%....
Ashford Hospitality (AHT) -29% after announces reverse stock split and announces preliminary RevPAR results for Q2 2021Provention Bio (PRVB) -22% after receiving CRL for teplizumab applicationDiDi Global (DIDI) -20% DiDi Global says app takedown in China may hurt...
Gainers: Sequential Brands Group (SQBG) +88%.Alector (ALEC) +50%.TAT Technologies (TATT) +43%.Marin Software (MRIN) +41%.Overseas Shipholding (OSG) +35%.Staffing 360 Solutions (STAF) +31%.Bridgeline Digital (BLIN) +31%.IDT (IDT) +21%.Nortech Systems (NSYS) +19%.Ocean Power Technologies (OPTT)...
Gainers: Alector (ALEC) +69%. Lucira Health (LHDX) +9%. Provention Bio (PRVB) +7%.Losers: Iterum Therapeutics (ITRM) -34%. Arrowhead Pharmaceuticals (ARWR) -26%. Alterity Therapeutics (ATHE) -21%. Citius Pharmaceuticals (CTXR) -20%. TRxADE HEALTH (MEDS) -17%. For fu...
Iterum Therapeutics (ITRM) -41% after FDA identifies deficiencies in sulopenem NDA.Arrowhead Pharmaceuticals (ARWR) -23% after pausing mid-stage AROENaC1001 study in cystic fibrosis.Birks Group (BGI) -13%.Alterity Therapeutics (ATHE) -12%.Kintara Therapeutics (KTRA) -8%.Ci...
Gainers: Alterity Therapeutics Limited (ATHE) +68%.TRxADE HEALTH (MEDS) +57%.Marin Software (MRIN) +45%.Bridgeline Digital (BLIN) +35%.Birks (BGI) +25%.Pulse Biosciences (PLSE) +25%.SGOCO Group (SGOC) +22%.Grid Dynamics Holdings (GDYN) +19%.scPharmaceuticals (SCPH) +18%.U.S. Silica Holdi...
Gainers: Alterity Therapeutics (ATHE) +103%, TRxADE HEALTH (MEDS) +62%, Pulse Biosciences (PLSE) +22%, Spero Therapeutics (SPRO) +12%, Kintara Therapeutics (KTRA) +6%.Losers: Citius Pharmaceuticals (CTXR) -21%, Aligos Therapeutics (A...
News, Short Squeeze, Breakout and More Instantly...
Alterity Therapeutics Limited Company Name:
ATHE Stock Symbol:
NYSE Market:
Alterity Therapeutics Limited Website:
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had Stable or Improved Neurological Symptoms – – Objective Biomarkers Demonstrated Improvement Consistent with Clinical Findings ...
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had Stable or Improved Neurological Symptoms – – Objective Biomarkers Demonstrated Improvement Consistent with Clinical Findings ...
MELBOURNE, Australia and SAN FRANCISCO, June 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today an...